Does Total Inferior and Middle Turbinectomy Always Lead to Empty Nose Syndrome?
Otolaryngology–Head and Neck Surgery · 2026-07 · 175 (1) · 71-77
DOI: 10.1002/ohn.70277 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, published online on 2026-05-05. Written by Nidhi Jha and 10 co-authors. Institution: Department of Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA. Major MEDLINE topics: Turbinates, Nasal Obstruction, Postoperative Complications. 15 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIDCD NIH HHS, National Institute on Deafness and Other Communication Disorders.
Abstract (original language)
Objective
Empty Nose Syndrome (ENS) is a rare and paradoxical complication often associated with aggressive turbinate reductions. Previous computational fluid dynamic (CFD) modeling has indicated that distorted nasal airflow patterns could contribute to ENS. However, no data have shown that aggressive turbinate reductions consistently lead to ENS. Study Design Retrospective case series.
Setting
Tertiary.
Methods
We retrospectively recruited 6 nasal obstruction patients who underwent turbinate reduction surgery, and performed total inferior and middle turbinectomies on all patients using a published virtual surgical simulator. We compared the CFD modeling results to that of patients' presurgery and postsurgery and published 27 ENS patients.
Results
As expected, the virtual turbinectomy significantly expanded nasal airway cross‐sectional area, more than that of actual surgery (inferior: 0.9 ± 0.4 to1.8 ± 0.3 cm 2 , middle: 0.6 ± 0.3 to 1.0 ± 0.3 cm 2 , all P < .01); however, it does not create the same distorted nasal airflow patterns as seen in ENS patients, with no significant difference in nasal resistance after actual surgery (0.12 ± 0.04 Pa/mL*s) versus virtual surgery (0.10 ± 0.03 Pa/mL*s) nor ENS (0.11 ± 0.04 Pa/mL*s, all P > .05). However, all had significantly higher inferior wall shear force (WSF) distribution, an important indicator of air/mucosa stimulation, than that of ENS patients (baseline 54.0 ± 11.9%, surgery: 51.5 ± 15.1%; virtual: 46.5 ± 11.5%, P > .05; ENS: 32.2% ± 12.5%, P < .001). The opposite was seen for the middle turbinate region—WSF among all actual or virtual surgeries conditions was significantly lower than that of the ENS group (baseline: 36.1 ± 11.0%; virtual: 30.2 ± 13.1%; ENS: 43.8 ± 10.1%; all P ≤ .05).
Conclusions
ENS cannot be solely attributed to aggressive turbinate reduction surgeries with various factors potentially playing a role.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.
- The Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
- Department of Otolaryngology, Nationwide Children's Hospital, Columbus, Ohio, USA.
ORCID profiles: Kai Zhao
Funding
- NIDCD NIH HHS
- National Institute on Deafness and Other Communication Disorders
Cite
APA
Jha, N., Speers, J., Odeh, A., Wu, Z., Mihalich, J., Gastineau, L. E., Hittle, B., Otto, B. A., Kelly, K. M., Wiet, G. J., & Zhao, K. (2026). Does Total Inferior and Middle Turbinectomy Always Lead to Empty Nose Syndrome?. Otolaryngology–Head and Neck Surgery, 175(1), 71-77. https://doi.org/10.1002/ohn.70277
Vancouver
Jha N, Speers J, Odeh A, Wu Z, Mihalich J, Gastineau LE, et al. Does Total Inferior and Middle Turbinectomy Always Lead to Empty Nose Syndrome?. Otolaryngology–Head and Neck Surgery. 2026;175(1):71-77. doi:10.1002/ohn.70277
BibTeX
@article{Jha2026,
author = {Jha, Nidhi and Speers, Jed and Odeh, Ahmad and Wu, Zhenxing and Mihalich, James and Gastineau, Lauren E and Hittle, Bradley and Otto, Bradley A and Kelly, Kathleen M and Wiet, Gregory J and Zhao, Kai},
title = {Does Total Inferior and Middle Turbinectomy Always Lead to Empty Nose Syndrome?},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
volume = {175},
number = {1},
pages = {71--77},
doi = {10.1002/ohn.70277}
}
EUVIMED